Skip to main content
Equibles
TCMD logo

TCMD · Tactile Systems Technology Inc · Metrics

Track TCMD — free

Use TCMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TCMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$23.54 +0.26 (+1.12%) At close · Oct 22
Russell 2000 member Rebalance outlook locked
Market Cap
$535.50M
Shares
22.65M
Volume · Oct 22 134.61K Avg daily vol (3M) 289.35K

TCMD metrics

112 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.54
Market cap
$535.50M

Price action

20 metrics
Price change (1W)
+1.1%
Price change (30D)
+3.8%
Price change (3M)
-14.2%
Price change (6M)
-3.7%
Price change (YTD)
-18.8%
Price change (1Y)
+57.8%
Trailing year
Price change (5Y)
-29.0%
52-week high
$33.05
52-week low
$14.92
Change from 52-week high
-28.8%
Change from 52-week low
+57.8%
Annualized volatility
62.9%
Annualized volatility (3M)
44.6%
Beta
0.8
RSI (14D)
57.4
Price vs SMA 50
+3.4%
Price vs SMA 200
-9.7%
Avg volume (3M)
289,346
Relative volume
0.5
Average dollar volume
$6.91M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
22.65M

Valuation

12 metrics
P / E (TTM)
22.0
Trailing earnings · reciprocal yield 4.5%
PEG ratio
0.2
EV / revenue
1.3×
reciprocal yield 75.2%
EV / EBITDA
11.2×
reciprocal yield 9.0%
EV / EBIT
13.3×
reciprocal yield 7.5%
P / sales
1.5×
reciprocal yield 65.4%
P / book
2.4
reciprocal yield 41.8%
FCF yield
5.0%
TTM · current market cap
Buyback yield
1.2%
P / FCF
20.0
reciprocal yield 5.0%
P / operating cash flow
17.5
reciprocal yield 5.7%
Earnings yield
4.6%

Historical valuation

8 metrics
P / E historical average (3Y)
22.7×
reciprocal yield 4.4%
P / E historical average (5Y)
96.1×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
1.1×
reciprocal yield 89.8%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 83.5%
EV / EBIT historical average (3Y)
14.7×
reciprocal yield 6.8%
EV / EBIT historical average (5Y)
21.6×
reciprocal yield 4.6%
EV / EBITDA historical average (3Y)
10.6×
reciprocal yield 9.4%
EV / EBITDA historical average (5Y)
20.8×
reciprocal yield 4.8%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-02
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
76.8%
Operating margin
10.0%
Trailing 12 months
Net margin
7.1%
Gross profit (TTM)
$268.97M
Operating profit (TTM)
$35.03M
Net income (TTM)
$24.86M
Trailing 12 months
Diluted EPS (TTM)
$1.07
FCF margin
7.7%
Effective tax rate
33.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$15.23
Gross profit per diluted share (TTM)
$11.69
Operating profit per diluted share (TTM)
$1.51
EBITDA per diluted share (TTM)
$1.80
Net income per diluted share (TTM)
$1.07
Operating cash flow per diluted share (TTM)
$1.31
Free cash flow per diluted share (TTM)
$1.15
Capital expenditures per diluted share (TTM)
$0.16
R&D per diluted share (TTM)
$0.44
Stock compensation per diluted share (TTM)
$0.36
Book value per share
$9.76

Growth

11 metrics
Revenue growth YoY
+8.6%
Year over year
Net income growth YoY
+142.0%
Revenue (TTM)
$350.31M
Trailing 12 months
EPS growth YoY
+142.9%
Shares change YoY
-0.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+10.1%
Revenue CAGR (5Y)
+12.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+127.6%
FCF CAGR (5Y)
+122.9%

Quality

14 metrics
Return on equity
11.1%
Return on assets
8.9%
Debt / equity
0.0
Current ratio
4.1
EBITDA (TTM)
$41.74M
Free cash flow (TTM)
$26.82M
Quick ratio
3.7
Interest coverage
139.6
Net debt / EBITDA
-1.7
Return on invested capital
15.1%
Trailing 12 months
Net cash
$69.85M
Latest balance sheet
Cash & equivalents
$69.85M
Total assets
$279.67M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$30.55M
Capital expenditures (TTM)
$3.73M
R&D (TTM)
$10.00M
SG&A (TTM)
—
Stock compensation (TTM)
$8.39M
R&D / revenue
2.9%
Stock compensation / revenue
2.4%

Ownership (13F)

9 metrics
13F filers
181
13F filer change QoQ
-5
Institutional ownership
97.0%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
38.9%
Private-fund adviser ownership
37.5%
Active holders' share change QoQ
+4.3%
Holder tenure
11.9
Price vs estimated holder cost
+51.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.6%

Short interest

3 metrics
Short interest
12.6%
Latest settlement · 9.9 days to cover
Days to cover
9.9d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$323,243
Insider-sentiment score
39 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1027838 CUSIP 87357P100 13F (30d) 20 filings 20 filers Visit website Investor relations